Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways.
about
Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentCombination chemotherapy regimen in a patient with metastatic malignant pheochromocytoma and neurofibromatosis type 1.The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review).Systemic therapies for malignant pheochromocytoma and paraganglioma can exacerbate hypertension.Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.
P2860
Sunitinib inhibits catecholamine synthesis and secretion in pheochromocytoma tumor cells by blocking VEGF receptor 2 via PLC-γ-related pathways.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@en
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@nl
type
label
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@en
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@nl
prefLabel
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@en
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@nl
P2093
P2860
P1476
Sunitinib inhibits catecholami ...... 2 via PLC-γ-related pathways.
@en
P2093
Hisato Hara
Hitoshi Shimano
Kazuhiro Takekoshi
Kiyo-aki Ishii
Tatsuhiko Ikeda
Yasushi Kawakami
Yuichi Aita
Yuria Saito
P2860
P304
P356
10.1152/AJPENDO.00156.2012
P577
2012-08-21T00:00:00Z